TREA

98130731 - ZYGEL

Follow

Information

  • Trademark
  • 98130731
  • Serial Number
    98130731
  • Filing Date
    August 14, 2023
    a year ago
  • Transaction Date
    March 11, 2024
    11 months ago
  • Status Date
    March 11, 2024
    11 months ago
  • Location Date
    March 11, 2024
    11 months ago
  • Status Code
    661
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    PAYABYAB, EDWARD TAN
  • Law Office Assigned Location Code
    O10
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
ZYGEL
Case File Statements
  • DM0000: The mark consists of the word "ZYGEL" in purple stylized text to the left of an arrangement of vertical and horizontal, yellow and orange rectangles with rounded ends featuring three purple teardrop shapes and two red teardrop shapes within a grid pattern created by the rectangles.
  • GS0051: Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders and all of the foregoing solely derived from manufactured synthetic cannabidiol and which do not contain delta-9 tetrahydrocannabinol (THC)
  • CC0000: The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.
Case File Event Statements
  • 3/11/2024 - 11 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/11/2024 - 11 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2024 - 11 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/5/2024 - a year ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/5/2024 - a year ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/5/2024 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/2/2023 - a year ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/27/2023 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/20/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/13/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/17/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP